Accelerating Alzheimer’s Prevention: A Global Imperative
Developed in collaboration with world-leading experts across academia, government and industry, our latest paper dives into the urgent global challenge of Alzheimer’s disease and highlights the groundbreaking potential of preventative interventions. Learn about the scientific breakthroughs, including the rise of disease-modifying therapies, that are paving the way for innovative solutions.
The Case for Regulatory Approval of Amyloid Lowering Immunotherapies in Alzheimer’s Disease | November 2024
Access the full paper here.